Cargando…
Copy number variations across the blood–brain barrier in multiple sclerosis
OBJECTIVE: Multiple sclerosis (MS) is a neuroinflammatory disease where immune cells cross the blood–brain barrier (BBB) into the central nervous system (CNS). What predisposes these immune cells to cross the BBB is still unknown. Here, we examine the possibility that genomic rearrangements could pr...
Autores principales: | Bedri, Sahl Khalid, Evertsson, Björn, Khademi, Mohsen, Al Nimer, Faiez, Olsson, Tomas, Hillert, Jan, Glaser, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268884/ https://www.ncbi.nlm.nih.gov/pubmed/35560551 http://dx.doi.org/10.1002/acn3.51573 |
Ejemplares similares
-
Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
por: Duell, Frida, et al.
Publicado: (2020) -
Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment
por: Bedri, Sahl Khalid, et al.
Publicado: (2019) -
A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis
por: Evertsson, Björn, et al.
Publicado: (2020) -
Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
por: McKay, Kyla A., et al.
Publicado: (2022) -
Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study
por: Karrenbauer, Virginija Danylaité, et al.
Publicado: (2021)